RxDoctor Payments Data

Bruce Schweiger, MD

Child & Adolescent Psychiatry · Cranford, NJNPI 1407958481

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 24.5% of the total. Reporting peaked in 2019 at $1,524 and has fallen 98.0% since, to $30 in 2025.

$1,996in general payments, 2019–2025

Across 137 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$489
  • Sunovion Pharmaceuticals Inc.$404
  • Teva Pharmaceuticals USA, Inc.$261
  • Takeda Pharmaceuticals U.S.A., Inc.$176
  • Otsuka America Pharmaceutical, Inc.$165
  • Johnson & Johnson$129
  • plus $372 from 8 others

What the payments were for

  • Food & beverage$1,92596%
  • Education$714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,996 in reported general payments places this provider in the 80th percentile of 137 child & adolescent psychiatry providers in New Jersey.

See all child & adolescent psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$20,497
Medicare patients
13
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl49$75,917
Wellbutrin XlBupropion Hcl13$35,402
TrintellixVortioxetine Hydrobromide48$27,951
RexultiBrexpiprazole16$27,859
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl87$18,391
ZoloftSertraline Hcl13$10,574
SaphrisAsenapine Maleate12$8,218
AdderallDextroamphetamine/Amphetamine11$7,331
Aripiprazole161$6,704
VyvanseLisdexamfetamine Dimesylate12$5,762
Alprazolam533$5,466
Bupropion XlBupropion Hcl177$4,300
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine137$3,969
Quetiapine Fumarate202$3,103
Divalproex Sodium ErDivalproex Sodium77$2,881

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Saphris$489$84,13661 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Adderall, Vyvanse$176$41,04471 claims
Otsuka America Pharmaceutical, Inc.Rexulti$165$27,85916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 137 child & adolescent psychiatry providers in New Jersey.

Other child & adolescent psychiatry in Cranford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →